Paul Tudor Jones’s GenMark Diagnostics, Inc GNMK Stock Holding History

Paul Tudor Jones’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-700,015	Closed	-$16.7M	–	2160
2021 Q1	$16.7M	Buy	+700,015	New	+$13M	0.34%	40
2020 Q4	–	Sell	-46,110	Closed	-$655K	–	1745
2020 Q3	$655K	Buy	46,110 +30,569	+197%	+$467K	0.03%	718
2020 Q2	$229K	Buy	+15,541	New	+$158K	0.01%	975
2020 Q1	–	Sell	-107,750	Closed	-$518K	–	1444
2019 Q4	$518K	Sell	107,750 -15,231	-12%	-$84K	0.02%	705
2019 Q3	$745K	Buy	122,981 +74,882	+156%	+$467K	0.03%	587
2019 Q2	$312K	Buy	+48,099	New	+$339K	0.01%	848
2017 Q3	–	Sell	-62,652	Closed	-$741K	–	1314
2017 Q2	$741K	Buy	+62,652	New	+$801K	0.02%	435

Paul Tudor Jones's GNMK Position: Q2 2021 in Review

Paul Tudor Jones sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 700,015 shares — an estimated $16.7M sold.

Paul Tudor Jones first reported a position in GNMK in Q2 2017 and held it in 7 quarters. The position peaked at $16.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Paul Tudor Jones reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Paul Tudor Jones sold 700,015 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $16.7M.
Paul Tudor Jones first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 7 quarters.
Paul Tudor Jones's GenMark Diagnostics, Inc position peaked at $16.7M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.